TISSUETECH, INC.

Basic Information

7000 SW 97 AVENUE SUITE 212
MIAMI, FL, 33173-1492

Company Profile

n/a

Additional Details

Field Value
DUNS: 167232888
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y
Number of Employees: n/a


  1. Prevention of Proliferative Vitreoretinopathy by HC-HA/PTX3

    Amount: $286,524.00

    DESCRIPTION provided by applicant Proliferative vitreoretinopathy PVR is characterized by membranes that develop on the surface of the retina after rhegmatogenous retinal detachments RRDs Beca ...

    SBIR Phase I 2015 Department of Health and Human Services National Institutes of Health
  2. Engineering of Human Corneal Endothelial Grafts

    Amount: $1,219,914.00

    DESCRIPTION (provided by applicant): The corneal endothelium plays a pivotal role in maintaining corneal transparency. Unlike in other species, the human corneal endothelium is notorious for its limit ...

    SBIR Phase II 2014 Department of Health and Human Services
  3. Engineering of Human Corneal Endothelial Grafts

    Amount: $1,219,914.00

    DESCRIPTION provided by applicant The corneal endothelium plays a pivotal role in maintaining corneal transparency Unlike in other species the human corneal endothelium is notorious for its limit ...

    SBIR Phase II 2014 Department of Health and Human Services National Institutes of Health
  4. Safety and Efficacy of Single-use Cliradex Pads for Ocular Mites

    Amount: $1,189,673.00

    DESCRIPTION (provided by applicant): Demodex mites are microscopic ectoparasites that commonly infest the pilosebaceous unit of the skin. Uncontrolled overgrowth of mites has been implicated in causin ...

    SBIR Phase II 2012 Department of Health and Human Services
  5. Amniotic Membrane versus Pericardium in Reducing Glaucoma Drainage Tube Exposure

    Amount: $997,132.00

    DESCRIPTION (provided by applicant): Glaucoma drainage devices (GDDs) have widely been used in the treatment of high-risk refractory glaucoma. To avoid tube exposure, which may lead to serious eye ...

    SBIR Phase II 2012 Department of Health and Human Services
  6. Engineering of Human Corneal Endothelial Grafts

    Amount: $210,593.00

    DESCRIPTION (provided by applicant): The corneal endothelium plays a pivotal role in maintaining corneal transparency. Unlike other species, the human corneal endothelium is notorious for its limited ...

    SBIR Phase I 2012 Department of Health and Human Services
  7. Anti-angiogenesis of HC-HA Covalent Complex and PTX3 Purified from Fetal Membrane

    Amount: $239,951.00

    DESCRIPTION (provided by applicant): Angiogenesis is a part of adult wound healing, which starts from inflammation and may end in scarring. When inflammation, angiogenesis, and scarring are well contr ...

    SBIR Phase I 2011 Department of Health and Human Services
  8. Phase II: Anti-inflammatory and Anti-scarring Actions of Amniotic Membrane Extra

    Amount: $935,580.00

    DESCRIPTION (provided by applicant): Over the past decade, there has been a surge of interest in amniotic membrane transplantation (AMT) for ocular surface reconstruction. A number of studies have sho ...

    SBIR Phase II 2010 Department of Health and Human Services
  9. Tea Tree Oil for Treating Ocular Demodex Infestation

    Amount: $112,409.00

    DESCRIPTION (provided by applicant): Demodex (folliculorum and brevis) mites are microscopic ectoparasites that commonly infest the pilosebaceous unit of the skin. Uncontrolled overgrowth of these mit ...

    SBIR Phase I 2009 Department of Health and Human Services
  10. Amniotic Membrane Patch Graft to Cover Glaucoma Drainage Tube

    Amount: $131,928.00

    DESCRIPTION (provided by applicant): Glaucoma drainage devices (GDDs) have widely been used in the treatment of high risk refractory glaucoma. To avoid tube exposure, which may lead to serious eye inf ...

    SBIR Phase I 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government